BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 403927)

  • 21. Binding of aggregated IgG BY HUMAN B lymphocytes independent of Fc receptors.
    Froland SS; Natvig JB; Michaelsen TE
    Scand J Immunol; 1974; 3(3):375-80. PubMed ID: 4546736
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunological characterization of lymphocytes in lymphoproliferative diseases. Restriction of classes, subclasses, and Gm allotypes of membrane-bound Ig.
    Froland SS; Natvig JB; Stavem P
    Scand J Immunol; 1972; 1(4):351-60. PubMed ID: 4590280
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunologic cell markers in lymphoproliferative diseases].
    Samoĭlova RS
    Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
    [No Abstract]   [Full Text] [Related]  

  • 24. T and B membrane markers on blast cells in 69 patients with acute lymphoblastic leukemia.
    Brouet JC; Toben HR; Chevalier A; Seligmann M
    Ann Immunol (Paris); 1974; 125 C(5):691-6. PubMed ID: 4617552
    [No Abstract]   [Full Text] [Related]  

  • 25. Malignant disease of the lymphoid system in immunological perspective.
    Hansen JA; Good RA
    Hum Pathol; 1974 Sep; 5(5):567-99. PubMed ID: 4137052
    [No Abstract]   [Full Text] [Related]  

  • 26. [T-lymphocyte subpopulation in the blood of patients with chronic lymphocytic leukemia].
    Holowiecki J; Stella B; Krawczyk M; Rudzka E
    Acta Haematol Pol; 1976; 7(2):111-6. PubMed ID: 1084671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute lymphoblastic leukaemia: a heterogenous disease.
    Haegert DG; Stuart J; Smith JL
    Br Med J; 1975 Feb; 1(5953):312-4. PubMed ID: 46154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosette formation with mouse erythrocytes: probable marker for human B lymphocytes.
    Gupta S; Grieco MH
    Int Arch Allergy Appl Immunol; 1975; 49(6):734-42. PubMed ID: 1081075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I; Diumenjo M
    Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
    [No Abstract]   [Full Text] [Related]  

  • 30. [Surface markers of lymphocytes in lymphoproliferative diseases].
    Burchardt K
    Pol Arch Med Wewn; 1976 Dec; 56(6):579-83. PubMed ID: 826893
    [No Abstract]   [Full Text] [Related]  

  • 31. [Surface markers of human lymphocyte subpopulations, their biological significance and a study of states of immunological deficits and lymphoproliferative disorders].
    Gupta S; Good RA
    Pol Arch Med Wewn; 1977 Feb; 57(2):149-72. PubMed ID: 403513
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunological characterization of lymphoproliferative disorders by membrane markers.
    Huber H; Michlmayr G; Huber C; Falkensammer M
    Klin Wochenschr; 1976 Aug; 54(15):699-708. PubMed ID: 790006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A human leukemia cell with both B and T cell surface receptors.
    Shevach E; Edelson R; Frank M; Lutzner M; Green I
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):863-6. PubMed ID: 4274561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte surface characteristics in malignant lymphoma.
    Aisenberg AC; Long JC
    Am J Med; 1975 Mar; 58(3):300-6. PubMed ID: 1090157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B- and T-cell markers on canine lymphosarcoma cells.
    Onions D
    J Natl Cancer Inst; 1977 Sep; 59(3):1001-6. PubMed ID: 302340
    [No Abstract]   [Full Text] [Related]  

  • 36. Editorial: B-cell and T-cell markers in lymphoid proliferations.
    Seligmann M
    N Engl J Med; 1974 Jun; 290(26):1483-4. PubMed ID: 4598692
    [No Abstract]   [Full Text] [Related]  

  • 37. Mouse red-cell rosettes in B-lymphoproliferative disorders.
    Catovsky D; Cherchi M; Okos A; Hegde U; Galton DA
    Br J Haematol; 1976 Jun; 33(2):173-7. PubMed ID: 1083742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface immunoglobulins on lymphocytes in chronic lymphocytic leukaemia and lymphosarcoma.
    Wilson JD; Hurdle AD
    Br J Haematol; 1973 May; 24(5):563-9. PubMed ID: 4541301
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell surface phenotype in lymphoproliferative disease.
    Aisenberg AC; Wilkes BM; Long JC; Harris NL
    Am J Med; 1980 Feb; 68(2):206-13. PubMed ID: 6965562
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and hematological heterogeneity of T-cell derived lymphoproliferative diseases.
    Brouet JC; Flandrin G
    Bull Cancer; 1977; 64(2):267-74. PubMed ID: 143976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.